Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
By Adding Patents, Drugmaker Keeps Cheaper Humira Copies Out of U.S.
Want Transparent Drug Prices? End Pharma’s Patent Abuse
California Says AbbVie Paid $1.2B In Kickbacks To Humira Ambassadors
Lawsuit: AbbVie Used Kickbacks and Nurse Ambassadors to Boost Humira Sales
AbbVie is accused of paying kickbacks, using a stealthy network of nurses to promote Humira
California Sues AbbVie Over Alleged Arthritis Drug Kickbacks
High drug prices: America’s migraine (and how to fix it)
‘Mentorship is a Conversation for Life’ Says the Mentor of This Social Entrepreneur
Submission to FTC on the Role of Intellectual Property
A Chinese twist in the tale involving Hepatitis C drug Sofosbuvir